MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Diabetes Treatment and Management
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

3,896 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
3,896 works in the cohort · of 4,299,418page 6 of 78

Labels cover 11 of 3,896 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 3,896 of 3,896 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

afffundaboutunlabeled
A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose‐lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study
Hertzel C. Gerstein, J.‐F. Yale, Stewart B. Harris, M. Issa, John A. Stewart, E. Dempsey
2006· article· en· Diabetic Medicine· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
195
citations
affunlabeled
Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers
Caroline Holm Nørgaard, Sarah Friedrich, Charlotte T. Hansen, Thomas Alexander Gerds, Clive Ballard, Daniél Vega Møller +6 more
2022· article· en· Alzheimer s & Dementia Translational Research & Clinical Interventions· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
193
citations
affunlabeled
Design and baseline characteristics of participants in the <scp>R</scp> esearching cardiovascular <scp>E</scp> vents with a <scp>W</scp> eekly <scp>IN</scp> cretin in <scp>D</scp> iabetes ( <scp>REWIND</scp> ) trial on the cardiovascular effects of dulaglutide
Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, Rafael Díaz, Mark Lakshmanan, Prem Pais +26 more
2017· article· en· Diabetes Obesity and Metabolism· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrowconsensus · metaepi_narrow
186
citations
affno abstractunlabeled
Liraglutide
Daniel J. Drucker, Argyris Dritselis, Peter Kirkpatrick
2010· review· en· Nature Reviews Drug Discovery· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · none
177
citations
← previousnext →

How this was built: Screen · Findings · About